Outcome of low-volume surgery for esophageal cancer in a high-volume referral center

Annals of Surgical Oncology

Volumn 16, Issue 12, 2009, Pages 3219-3226

  Courrech Staal, Ewout F W ^a   Van Coevorden, Frits ^a   Cats, Annemieke ^a   Aleman, Berthe M P ^a   Van Velthuysen, Marie Louise F ^a   Boot, Henk ^a   Vrancken Peeters, Marie Jeanne T F D ^a   Van Sandick, Johanna W ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HEALTH CARE QUALITY; HISTOPATHOLOGY; HOSPITAL UTILIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RECURRENCE RISK; SURVIVAL TIME; WORKLOAD;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 71549144448     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0700-5     Document Type: Article

References (29)

1. JB Hulscher JG Tijssen H Obertop JJ van Lanschot 2001 Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis Ann Thorac Surg. 72 306 313 10.1016/S0003-4975(00)02570-4 1:STN:280: DC%2BD3Mvhs1ejsw%3D%3D 11465217 (Pubitemid 32643075)
2. DM Parkin FI Bray SS Devesa 2001 Cancer burden in the year 2000. The global picture Eur J Cancer 37 Suppl 8 S4 S66 10.1016/S0959-8049(01)00267-2 11602373
3. Visser OCJ, Schouten LJ, van Dijk JAAM. Incidence of cancer in the Netherlands 1997. Vereniging van Integrale Kankercentra: Utrecht; 2001.
4. V Gebski B Burmeister BM Smithers K Foo J Zalcberg J Simes 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol. 8 226 234 10.1016/S1470-2045(07)70039-6 1:CAS:528:DC%2BD2sXisVCqs78%3D 17329193 (Pubitemid 46291702)
5. JD Birkmeyer TA Stukel AE Siewers PP Goodney DE Wennberg FL Lucas 2003 Surgeon volume and operative mortality in the United States N Engl J Med. 349 2117 2127 10.1056/NEJMsa035205 1:CAS:528:DC%2BD3sXptlKhsL0%3D 14645640 (Pubitemid 37464537)
6. SD Killeen MJ O'Sullivan JC Coffey WO Kirwan HP Redmond 2005 Provider volume and outcomes for oncological procedures Br J Surg. 92 389 402 10.1002/bjs.4954 1:STN:280:DC%2BD2M7mtVWrtA%3D%3D 15786424 (Pubitemid 40523899)
7. MM Chowdhury H Dagash A Pierro 2007 A systematic review of the impact of volume of surgery and specialization on patient outcome Br J Surg. 94 145 161 10.1002/bjs.5714 1:STN:280:DC%2BD2s%2Fns1WjsA%3D%3D 17256810 (Pubitemid 46340392)
8. AA Forastiere MB Orringer C Perez-Tamayo SG Urba M Zahurak 1993 Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report J Clin Oncol. 11 1118 1123 1:STN:280: DyaK3s3nsVegug%3D%3D 8501498
9. TN Walsh N Noonan D Hollywood A Kelly N Keeling TP Hennessy 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med. 335 462 467 10.1056/NEJM199608153350702 1:STN:280: DyaK283psF2juw%3D%3D 8672151 (Pubitemid 26269945)
10. M Al Sarraf K Martz A Herskovic, et al. 1997 Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study J Clin Oncol. 15 277 284 1:CAS:528:DyaK2sXnsV2mtg%3D%3D 8996153
11. MB Polee A Sparreboom FA Eskens, et al. 2004 A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer Clin Cancer Res. 10 1928 1934 10.1158/1078-0432. CCR-03-0319 1:CAS:528:DC%2BD2cXisVGlurs%3D 15041708 (Pubitemid 38375549)
12. BF El Rayes A Shields M Zalupski, et al. 2004 A phase II study of carboplatin and paclitaxel in esophageal cancer Ann Oncol 15 960 965 10.1093/annonc/mdh230 1:STN:280:DC%2BD2c3lt12jtQ%3D%3D 15151955 (Pubitemid 39004354)
13. H Wang J Ryu D Gandara, et al. 2007 A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer J Thorac Oncol. 2 153 157 10.1097/JTO.0b013e31802bff75 17410032 (Pubitemid 47181345)
14. A Bamias ME Hill D Cunningham, et al. 1996 Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival Cancer. 77 1978 1985 10.1002/(SICI)1097-0142(19960515)77:10<1978::AID-CNCR3>3.0.CO;2-D 1:CAS:528:DyaK28XjtFGrsLs%3D 8640659 (Pubitemid 26142038)
15. TR Evans G Pentheroudakis J Paul, et al. 2002 A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma Ann Oncol. 13 1469 1478 10.1093/annonc/mdf243 1:STN:280:DC%2BD38vpvV2mtA%3D%3D 12196374
16. Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002.
17. MB Orringer B Marshall AC Chang J Lee A Pickens CL Lau 2007 Two thousand transhiatal esophagectomies: changing trends, lessons learned Ann Surg. 246 363 372 10.1097/SLA.0b013e31814697f2 17717440
18. SM Lagarde JD de Boer FJ Ten Kate OR Busch H Obertop JJ van Lanschot 2008 Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence Ann Surg. 247 71 76 10.1097/SLA.0b013e31815b695e 18156925
19. MW Wouters BP Wijnhoven HE Karim-Kos, et al. 2008 High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data Ann Surg Oncol. 15 80 87 10.1245/s10434-007- 9673-4 18004627
20. AR Davies MJ Forshaw AA Khan AS Noorani VM Patel DC Strauss, et al. 2008 Transhiatal esophagectomy in a high volume institution World J Surg Oncol. 6 88 10.1186/1477-7819-6-88 18715498
21. M Rutegard J Lagergren I Rouvelas P Lagergren 2009 Surgeon volume is a poor proxy for skill in esophageal cancer surgery Ann Surg. 249 256 261 10.1097/SLA.0b013e318194d1a5 19212179
22. A Ruol C Castoro G Portale, et al. 2009 Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution Arch Surg. 144 247 254 10.1001/archsurg.2008.574 19289664
23. SM Lagarde JB Reitsma AK Maris, et al. 2008 Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram Ann Thorac Surg. 85 1938 1945 10.1016/j.athoracsur.2008.03. 014 18498798 (Pubitemid 351685608)
24. PC Enzinger RJ Mayer 2003 Esophageal cancer N Engl J Med. 349 2241 2252 10.1056/NEJMra035010 1:CAS:528:DC%2BD3sXps1WhsL8%3D 14657432 (Pubitemid 37485141)
25. SG Urba MB Orringer A Turrisi M Iannettoni A Forastiere M Strawderman 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol. 19 305 313 1:CAS:528:DC%2BD3MXhtVektrs%3D 11208820
26. EJ Nieveen van Dijkum LT de Wit OM van Delden EA Rauws JJ van Lanschot H Obertop, et al. 1997 The efficacy of laparoscopic staging in patients with upper gastrointestinal tumors Cancer. 79 1315 1319 10.1002/(SICI)1097-0142(19970401) 79:7<1315::AID-CNCR7>3.0.CO;2-F 1:STN:280:DyaK2s3js1CmtA%3D%3D 9083152 (Pubitemid 27143237)
27. JJ van Lanschot JB Hulscher CJ Buskens HW Tilanus FJ Ten Kate H Obertop 2001 Hospital volume and hospital mortality for esophagectomy Cancer. 91 1574 1578 10.1002/1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2 11301408 (Pubitemid 32319271)
28. M Rodgers BA Jobe RW O'Rourke B Sheppard B Diggs JG Hunter 2007 Case volume as a predictor of inpatient mortality after esophagectomy Arch Surg. 142 829 839 10.1001/archsurg.142.9.829 17875837 (Pubitemid 47437297)
29. DR Urbach NN Baxter 2004 Does it matter what a hospital is "high volume" for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data BMJ. 328 737 740 10.1136/bmj.38030.642963.AE 15020356